Publication:


abstract

In this study, we aimed to examine the effects of a plant-extractive compound on lipid profiles in subjects with metabolic syndrome. We hypothesized that extractives from red yeast rice, bitter gourd, chlorella, soy protein, and licorice have synergistic benefits on cholesterol and metabolic syndrome. In this double-blinded study, adult subjects with metabolic syndrome were randomized to receive a plant-extractive compound or a placebo treatment for 12 weeks. Both total cholesterol (5.4 ± 0.8 to 4.4 ± 0.6 mmol/L, P < .001) and low-density lipoprotein cholesterol (3.4 ± 0.7 to 2.7 ± 0.5 mmol/L, P < .001) were significantly reduced after treatment with the plant extractives, and the magnitudes of reduction were significantly greater than in the placebo group (-1.0 ± 0.6 vs 0.0 ± 0.6mmol/L, P < .001; -0.7 ± 0.6 vs 0.0 ± 0.6 mmol/L, P < .001). The reduction in the fasting triglycerides level was significantly greater in the plant-extractive group than in the placebo group (-0.5 ± 0.8 vs -0.2 ± 1.0 mmol/L, P = .039). There was also a significantly greater reduction in the proportion of subjects with hypertensive criteria in the plant-extractive group than in the placebo group (P = .040). In conclusion, the plant extractives from red yeast rice, bitter gourd, chlorella, soy protein, and licorice were effective in reducing total and low-density lipoprotein cholesterol. The plant extractives also showed potential for reducing triglyceride and normalizing blood pressure.

Copyright © 2012 Elsevier Inc. All rights reserved.

Related Articles
Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial.
Ann Intern Med. 2009
Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial.
Becker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ. Ann Intern Med. 2009 Jun 16; 150(12):830-9, W147-9.
Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women.
J Clin Endocrinol Metab. 2001
Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women.
Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S, McGrath BP. J Clin Endocrinol Metab. 2001 Jul; 86(7):3053-60.
A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) study.
Clin Ther. 2003
A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) study.
Olsson AG, Eriksson M, Johnson O, Kjellström T, Lanke J, Larsen ML, Pedersen T, Tikkanen MJ, Wiklund O, 3T Study Investigators. Clin Ther. 2003 Jan; 25(1):119-38.
Review The comparative efficacy of plant sterols and stanols on serum lipids: a systematic review and meta-analysis.
J Am Diet Assoc. 2010
Review The comparative efficacy of plant sterols and stanols on serum lipids: a systematic review and meta-analysis.
Talati R, Sobieraj DM, Makanji SS, Phung OJ, Coleman CI. J Am Diet Assoc. 2010 May; 110(5):719-26.
Review Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies.
J Am Coll Nutr. 2011
Review Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies.
Anderson JW, Bush HM. J Am Coll Nutr. 2011 Apr; 30(2):79-91.